Drug delivery from engineered organisms and nanocarriers as monitored by multimodal imaging technologies
In recent years, while the research budget and development times increased for different phases of drug development, the number of clinically approved new medicines declined. In fact, many promising drug candidates failed to demonstrate their full therapeutic potential <em>in vivo</em>....
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
AIMS Press
2017-03-01
|
Series: | AIMS Bioengineering |
Subjects: | |
Online Access: | http://www.aimspress.com/Bioengineering/article/1322/fulltext.html |